Definitive Healthcare Q3 2026 Results: Net Loss of $3.89M, Loss Narrows
Definitive Healthcare Corp. filed its Q3 2026 Form 10-Q reporting 107,163,253 shares of Class A common stock outstanding as of November 2, 2026. The report highlights key operational risks including dependence on third-party data, the transition of its Chief Executive Officer, and potential transactions involving Advent International.
- Key figure
- Net loss $3.89M